Aptamers and the next generation of diagnostic reagents

Proteomics - Clinical Applications

Volumn 6, Issue 11-12, 2012, Pages 563-573

  Thiviyanathan, Varatharasa ^a   Gorenstein, David G ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Aptamer chips; Bead based selection; Cancer biomarkers; Thioaptamers; X aptamers

Indexed keywords

APTAMER; BIOLOGICAL MARKER; DIAGNOSTIC AGENT;

ANTIBODY PRODUCTION; BINDING AFFINITY; CHEMICAL MODIFICATION; COMBINATORIAL CHEMISTRY; EARLY DIAGNOSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; PROTEIN TERTIARY STRUCTURE; PROTEOMICS; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

APTAMERS, NUCLEOTIDE; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; INDICATORS AND REAGENTS; PROTEOMICS; SELEX APTAMER TECHNIQUE;

EID: 84871417805     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201200042     Document Type: Review

References (123)

1. Brody, E. N., Gold, L., Lawn, R. M., Walker, J. J. et al., High-content affinity-proteomics: unlocking protein biomarker discovery. Expert Rev. Mol. Diagn. 2010, 10, 1013-1022.
2. Ritz, J., Pesando, J. M., McConarty, N. J., Clavell, L. A. et al., Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. Cancer Res. 1981, 41, 4771-4775.
3. Borrebaeck, C. A., Antibodies in diagnostics- from immunoassays to protein chips. Immunol. Today 2000, 21, 379-382.
4. Leong, T. Y., Cooper, K., Leong, A. S., Immunohistology: past, present and future. Adv. Anat. Pathol. 2010, 17, 404-418.
5. Bouchard, P. R., Hutabarat, R. M., Thompson, K. M., Discovery and development of therapeutic aptamers. Annu. Rev. Pharmacol. Toxicol. 2010, 50, 237-257.
6. Brody, E. N., Gold, L., Aptamers as therapeutic and diagnostic agents. J. Biotechnol. 2000, 74, 5-13.
7. Jayasena, S. D., Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 1999, 45, 1628-1650.
8. Keefe, A. D, Pai, S., Ellington, A., Aptamers as therapeutics. Nat. Rev. Drug Discov. 2010, 9, 537-550.
9. Hong, H., Goel, S., Zhang, Y., Cai, W., Molecular imaging with nucleic acid aptamers. Curr. Med. Chem. 2011, 18, 195-205.
10. Mann, A. P., Bhavane, R. C., Somasunderam, A., Montalvo-Oritz, B. et al., Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget 2011, 2, 298-304.
11. Tuerk, C., Gold, L., Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990, 249, 505-510.
12. Ellington, A. D., Szostak, J. W., In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346, 818-822.
13. Eaton, B. E., Gold, L., Zichi, D. A., Lets get specific: the relationship between specificity and affinity. Chem. Biol. 1995, 2, 633-638.
14. Bridonneau, P., Chang, Y. F., O'Connell, D., Gill, S. C. et al., High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2. J. Med. Chem. 1998, 41, 778-786.
15. Hermann, T., Patel, D. J., Adaptive recognition by nucleic acid aptamers. Science 2000, 287, 820-825.
16. Fredriksson, S., Gullberg, M., Jarvius, J., Olsson, C. et al., Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 2002, 20, 473-477.
17. Conrad, R., Ellington, A. D., Detecting immobilized protein kinase C isozymes with RNA aptamers. Anal. Biochem. 1996, 242, 261-265.
18. Conrad, R., Keranen, L. M., Ellington, A. D., Newton, A. C., Isozyme-specific inhibition of protein kinase C by RNA aptamers. J. Biol. Chem. 1994, 269, 32051-32054.
19. Jenison, R. D., Gill, S. C., Pardi, A, Polisky, B., High-resolution molecular discrimination by RNA. Science. 1994, 263, 1425-1429.
20. Ng, E. W., Adamis, A. P., Anti-VEGF aptamer therapy for ocular vascular diseases. Ann. NY Acad. Sci. 2006, 1082, 151-171.
21. Ireson, C. R., Kelland, L. R., Discovery and development of anticancer aptamers. Mol. Cancer Ther. 2006, 5, 2957-2962.
22. Dausse, E., Gomes, S. D. R., Toulme, J-J., Aptamers: a new class of oligonucleotides in the drug discovery pipeline. Curr. Opin. Pharm. 2009, 9, 602-607.
23. Connell, G. J., Illangesekare, M., Yarus, M., Three small ribonucleotides with specific arginine sites. Biochemistry 1993, 32, 5497-5502.
24. Geiger, A., Burgstaller, P., von der Eltz, H., Roeder, A., Famulok, M., RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res. 1996, 24, 1029-1036.
25. 2+ binding RNA motifs with an asymmetric purine-rich internal loop and a G:A base pair. RNA 1997, 3, 1289-1300.
26. Rajendran, M., Ellington, A. D., Selection of fluorescent aptamer beacons that light up in the presence of zinc. Anal Bioanal. Chem. 2008, 390, 1067-1075.
27. Nieuwlandt, D., Wecker, M., Gold, L., In vitro selection of RNA ligands to substance P. Biochemistry 1995, 34, 5651-5659.
28. Williams, K. P., Liu, X. H., Schumacher, T. N., Lin, H. Y. et al., Bioactive and nuclease-resistant l-DNA ligand of vasopressin. Proc. Natl. Acad. Sci. USA 1997, 94, 11285-11290.
29. Tuerk, C., MacDougal, S., Gold, L., RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 1992, 89, 6988-6992.
30. Kubik, M. F., Stephens, A. W., Schneider, D., Marlar, R. A., Tasset, D., High-affinity RNA ligands to human α-thrombin. Nucleic Acids Res. 1994, 22, 2619-2626.
31. Somasunderam, A., Ferguson, M. R., Rojo, D. R., Thiviyanathan, V. et al., Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase. Biochemistry 2005, 44, 10388-10395.
32. Kang, J, Lee, M. S., Watowich, S. J., Gorenstein, D. G., Combinatorial selection of a RNA thioaptamer that binds to Venezuelan equine encephalitis virus capsid protein. FEBS Lett. 2007, 581, 2497-2502.
33. Urvil, P. T., Kakiuchi, N., Zhou, D. M., Shimotohno, K. et al., Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus. Eur. J. Biochem. 1997, 248, 130-138.
34. Morris, K. N., Jensen, K. B., Julin, C. M., Weil, M., Gold, L., High affinity ligands from in vitro selection: complex targets. Proc. Natl. Acad. Sci. USA 1998, 95, 2902-2907.
35. Blank, M., Weinschenk, T., Priemer, M., Schluesener, H., Systematic evolution of a DNA aptamer binding to rat brain tumor micro vessels; selective targeting of endothelial regulatory protein pigpen. J. Biol. Chem. 2001, 276, 16464-16468.
36. Hicke, B. J., Marion, C., Chang, Y. F., Gould, T. et al., Tenascin-C aptamers are generated using tumor cells and purified protein. J. Biol. Chem. 2001, 276, 48644-48654.
37. Sefah, K., Phillips, J. A., Xiong, X., Meng, L. et al., Molecular recognition of acute myeloid leukemia using aptamers. Leukemia 2009, 23, 235-244.
38. Shangguan, D., Meng, L., Cao, Z. C., Xiao, Z. et al., Identification of liver cancer-specific aptamers using whole live cells. Anal. Chem. 2008, 80, 721-728.
39. Pan, W., Craven, R. C., Qiu, Q., Wilson, C. B. et al., Isolation of virus-neutralizing RNAs from a large pool of random sequences. Proc. Natl. Acad. Sci. USA 1995, 92, 11509-11513.
40. Misono, T. S., Kumar, P. K. R., Selection of RNA aptamers against human influenza virus hemagglutinin using surface Plasmon resonance. Anal. Biochem. 2005, 342, 312-317.
41. Tang, Z., Parekh, P., Turner, P., Moyer, R. W., Tan, W., Generating aptamers for recognition of virus-infected cells. Clin. Chem. 2009, 55, 813-822.
42. Wilson, D. S., Szostak, J. W., In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 1999, 68, 611-647.
43. Bielinska, A., Shivdasani, R. A., Zhang, L. Q., Nabel, G. J., Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science 1990, 250, 997-1000.
44. Lebruuska, L. L., Maher, L. J., Selection and characterization of an RNA decoy for transcription factor NF-kappa B. Biochemistry 1999, 38, 3168-3174.
45. Fennewald, S. M., Scott, E. P., Zhang, L., Yang, X. et al., Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections. J. Gen Virol. 2007, 88, 981-990.
46. King, D. J., Bassett, S. E., Li, X., Fennewald, S. A. et al., Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA (p65) and p50. Biochemistry 2002, 41, 9696-9706.
47. Sharifi, J., Khawli, L. A., Hornick, J. L., Epstein, A. L., Improving monoclonal antibody pharmacokinetics via chemical modification. Q. J. Nucl. Med. 1988, 42, 242-249.
48. Constantinou, A., Chen, C., Deonarain, M. P., Modulating the pharmacokinetics of therapeutic antibodies. Biotechnol. Lett. 2010, 32, 609-622.
49. Stoltenburg, R., Reinemann, C., Strehlitz, B., FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal. Bioanal. Chem. 2005, 383, 83-91.
50. Cox, J. C., Rudolph, P., Ellington, A. D., Automated RNA selection. Biotechnol. Prog. 1998, 14, 845-850.
51. Cox, J. C., Ellington, A. D., Automated selection of anti-protein aptamers. Bioorg. Med. Chem. 2001, 9, 2525-2531.
52. King, D. J., Ventura, D. A., Brasier, A. R., Gorenstein, D. G., Novel combinatorial selection of phosphorothioate oligonucleotide aptamers. Biochemistry 1998, 37, 16489-16493.
53. Vaught, J. D., Dewey, T., Eaton, B. E., T7 RNA polymerase transcription with 5-position modified UTP derivatives. J. Am. Chem. Soc. 2004, 126, 11231-11237.
54. Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M. et al., Expanding the chemistry of DNA for in vitro studies. J. Am. Chem. Soc. 2010, 132, 4141-4151.
55. White, R. R., Sullenger, B. A., Rusconi, C. P., Developing aptamers into therapeutics. J. Clin. Invest. 2000, 106, 929-934.
56. Faria, M., Ulrich, H., Sugar boost: when ribose modifications improve oligonucleotide performance. Curr. Opin. Mol. Ther. 2008, 10, 168-175.
57. Pieken, W. A., Olsen, D. B., Benseler, F., Aurup, H., Eckstein, F., Kinetic characterization of ribonuclease-resistant 2́-modified hammerhead ribozymes. Science 1991, 253, 314-317.
58. Crinelli, R., Bianchi, M., Gentilini, L., Magnani, M., Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res. 2002, 30, 2435-2443.
59. Darfeuille, F., Hansen, J. B., Orum, H., Di Primo, C., Toulme, J. J., LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1. Nucleic Acids Res. 2004, 32, 3101-3107.
60. Ulrich, H., Martins, A. H., Pesquero, J. B., RNA and DNA aptamers in cytomics analysis. Cytometry Part A 2004, 59A, 220-231.
61. Schmidt, K. S., Borkowski, S., Kurreck, J., Stephens, A. W. et al., Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Nucleic Acids Res. 2004, 32, 5757-5765.
62. Thiviyanathan, V., Somasunderam, A., Gorenstein, D. G., Combinatorial selection and delivery of thioaptamers. Biochem. Soc. Trans. 2007, 35, 50-52.
63. Kang J, Lee, M. S., Copland, J. A. 3rd, Luxon, B. A., Gorenstein, D. G., Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein. Bioorg. Med. Chem. Lett. 2008, 18, 1835-1839.
64. Mann, A. P, Somasunderam, A, Nieves-Alicea, R., Li, X. et al., Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting. PLoS One. 2010, 5, e13050.
65. Andreola, M. L., Calmels, C., Michel, J., Toulme, J. J., Litvak, S., Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides. Eur. J Biochem. 2000, 267, 5032-5040.
66. Jhaveri, S, Olwin, B, Ellington, A. D., In vitro selection of phosphorothiolated aptamers. Bioorg. Med. Chem. Lett. 1998, 8, 2285-2290.
67. King, D. J., Safar, J. G., Legname, G, Prusiner, S. B., Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites. J. Mol. Biol. 2007, 369, 1001-1014.
68. Yang, X., Gorenstein, D. G., Progress in thioaptamers development. Curr. Drug Targets 2004, 5, 705-715.
69. Volk, D. E., Power, T. D., Gorenstein, D. G., Luxon, B. A., An ab initio study of phosphorothioate and phosphorodithioate interactions with sodium cation. Tet. Lett. 2002, 43, 4443-4447.
70. Keefe, A. D., Cload, S. T., SELEX with modified nucleotides. Curr. Opin. Chem. Biol. 2008, 12, 448-456.
71. Smith, J. S., Nikonowicz, E. P., Phosphorothioate substitution can substantially alter RNA conformation. Biochemistry 2000, 39, 5642-5652.
72. Lebedev, A. V., Wickstrom, E., The chirality problem in P-substituted oligonucleotides. Pres. Drug Discov. Design 1996, 4, 17-40.
73. Kraemer, S., Vaught, J. D., Bock, C., Gold, L. et al., From SOMAmer-based biomarker discovery to diagnostic and clinical applications; a SOMAmer-based, streamlined multiplex proteomic assay. PLoS One 2011, 6, e26332.
74. Demko, Z., Sharpless, B. A., A click chemistry approach to tetrazoles by Huisgen 1, 3-dipolar cycloaddition: synthesis of 5-acyltetrazoles from azides and acyl cyanides. Angew. Chem. Int. Ed. 2002, 41, 2113---2116.
75. Binder, W. H., Sachsenhofer, R., Click chemistry in polymer and material science. Macromol. Rapid Commun. 2007, 28, 15-54.
76. Gramlich, P. M. E., Wirges, C. T., Manetto, A., Carell, T., Post synthetic DNA modification through the copper-catalyzed azide-alkyne cycloaddition reaction. Angew. Chem. Int. Ed. 2008, 47, 8350-8358.
77. Vaught, J. D., Bock, C., Carter, J., Fitzwater, T et al., Expanding the chemistry for in vitro selection. J. Am. Chem. Soc. 2010, 132, 4141-4145.
78. Somasunderam, A., Thiviyanathan, V., Tanaka, T., Li, X. et al., Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44. Biochemistry 2010, 49, 9106-9112.
79. Collett, J. R., Cho, E. J., Ellington, A. D., Production and processing of aptamer microarrays. Methods 2005, 37, 4-15.
80. Platt, M., Rowe, W., Wedge, D. C., Kell, D. B. et al., Aptamer evolution for array-based diagnostics. Anal. Biochem. 2009, 390, 203-205.
81. Eulberg, D., Buchner, K., Maasch, C., Klussmann, S., Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist. Nucleic Acids Res. 2005, 33, e45.
82. Blank M, Blind M., Aptamers as tools for target validation. Curr. Opin. Chem. Biol. 2005, 9, 336-342.
83. Shangguan, D., Li, Y., Tang, Z., Cao, Z. C. et al., Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. USA. 2006, 103, 11838-11843.
84. Cerchia, L., Duconge, F., Pestourie, C., Boulay, J. et al., Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 2005, 3, e123.
85. Daniels, D. A, Chen, H, Hicke, B. J., Swiderek, K. M., Gold, L., A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl. Acad. Sci. USA 2003, 100, 15416-15421.
86. Li, N., Ebright, J. N., Stovall, G. M., Chen, X. et al., Technical and biological issues relevant to cell typing with aptamers. J. Proteome Res. 2009, 8, 2438-2448.
87. Guo, K. T., Ziemer, G., Paul, A, Wendel, H. P., CELL-SELEX: novel perspectives of aptamer-based therapeutics. Int. J. Mol. Sci. 2008, 9, 668-678.
88. Fang, X, Tan, W., Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc. Chem. Res. 2010, 43, 48-57.
89. Francica, J. R., Varela-Rohena, A., Medvec, A., Plesa, G. et al., Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein. PLoS Pathogens 2010, 6, e1001098.
90. Yang, X., Li, N., Gorenstein, D. G., Strategies for the discovery of therapeutic aptamers. Expert Opin. Drug Discov. 2001, 6, 75-87.
91. Yang, X., Bassett, S. E., Li, X., Luxon, B. A. et al., Construction and selection of bead-bound combinatorial oligonucleotide phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Res. 2002, 30, e132.
92. Yang, X., Li, X., Prow, T. W., Reece, L. M. et al., Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers. Nucleic Acids Res. 2003, 31, e54.
93. Yang, X., Wang, H., Beasley, D. W., Volk, D. E. et al., Selection of thioaptamers for diagnostics and therapeutics. Ann. NY Acad. Sci. 2006, 1082, 116-119.
94. Meyers, L. A., Lee, J, F., Cowperthwaite, M., Ellington, A. D., The robustness of naturally and artificially selected nucleic acid secondary structures. J. Mol. Evol. 2004, 58, 681-691.
95. Tsuji, S., Hirabayashi, N., Kato, S., Akitomi, J., et al., Effective isolation of RNA aptamer through suppression of PCR bias. Biochem. Biophys. Res. Commun. 2009, 386, 223-226.
96. Porschewski, P., Grattinger, M., Klenzke, K., Erpenback, A. et al., Using aptamers as capture reagents in bead-based assay systems for diagnostics and hit identification. J. Biomol. Screening 2006, 11, 773-781.
97. O'Farrell, P. H., The pre-omics era: the early days of two-dimensional gels. Proteomics 2008, 8, 4842-4852.
98. Fredriksson, S., Dixon, W., Ji, H., Koon, A. C. et al., Multiplexed protein detection by proximity ligation for cancer biomarker validation. Nat. Meth. 2007, 4, 327-329.
99. Schweitzer, B., Roberts, S., Grimwade, B., Shao, W. et al., Multiplexed protein profiling on micoarrays by rolling-cycle amplification. Nat. Biotechnol. 2002, 20, 359-365.
100. Drolet DW, Moon-McDermott, L., Romig, T. S., An enzyme-linked oligonucleotide assay. Nat. Biotechnol. 1996, 14, 1021-1025.
101. Agnew, H. D., Rohde, R. D., Millward, S. W., Nag, A. et al., Iterative in situ click chemistry creates antibody-like protein-capture agents. Angew Chem. Int. Ed. Engl. 2009, 48, 4944-4948.
102. Zhu, J., Li, T., Hu, J., Wang, E., A novel dot-blot DNAzyme-linked aptamer assay for protein detection. Anal. Bioanal. Chem. 2010, 397, 2923-2927.
103. Tombelli, S., Mascini, M., Aptamers as molecular tools for bioanalytical methods. Curr. Opin. Mol. Ther 2009, 11, 179-188.
104. Shin, S., Kim, I-H, Kang, W., Yang, J. K., Hah, S. S., An alternative to Western blot analysis using RNA aptamer-functionalized quantum dots. Bioorg. Med. Chem. Lett 2010, 20, 3322-3325.
105. Joshi, R., Janagama, H., Dwivedi, H. P., Senthilkumar, T. M. A. et al., Selection, characterization, and application of DNA aptamers for the capture and detection of Salmonella enterica serovars. Mol. Cell. Probes 2009, 23, 20-28.
106. Proschewski, P., Grattinger, M., Klenzke, K., Erpenbach, A. et al., Using aptamers as capture reagents in bead-based assay systems for diagnostics and hit identification. J. Biomol. Screen 2006, 11, 773-781.
107. Rye, P. D., Nustad, K., Immunomagnetic DNA aptamer assay. Biotechniques 2001, 30, 290-292.
108. Baldrich, E, Acero, J. L., Reekmans, G., Laureyn, W., O'Sullivan, C. K., Displacement enzyme linked aptamer assay. Anal. Chem. 2005, 77, 4774-4784.
109. Wang, H., Yang, X., Bowick, G. C., Herzog, N. K. et al., Identification of proteins bound to a thioaptamers probe on a proteomics array. Biochem. Biophys. Res. Commun. 2006, 347, 586-593.
110. Gold, L., Ayers, D., Bertino, J., Bock, C. et al., Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 2010, 5, e15004.
111. Ostroff, R. M., Bigbee, W. L., Franklin, W., Gold, L. et al., Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 2010, 5, e15003.
112. Kraemer, S., Vaught, J. D., Bock, C., Gold, L. et al., From aptamer-based biomarker discovery to diagnostic and clinical applications: an aptamer based, streamlined multiplex proteomic assay. Nat. Preceding 2010, 4642.1.
113. Berezovski, M. V., Lechmann, M., Musheev, M. U., Mak, T. W, Krylov, S. N., Aptamer-facilitated biomarker discovery (AptaBiD). J. Am. Chem. Soc. 2008, 130, 9137-9143.
114. Ahn, J. Y., Lee, S. W., Kang, H. S., Jo, M., et al., Aptamer microarray mediated capture and mass spectrometry identification of biomarker in serum samples. J. Proteome Res. 2010, 9, 5568-5573.
115. Cole, J. R., Dick, L. W., Jr., Morgan, E. J., Linda, B., McGown, L. B., Affinity capture and detection of immunoglobulin E in human serum using an aptamer-modified surface in matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 2007, 79, 273-279.
116. Keller, K. M., Breeden, M. M., Zhang, J, Ellington, A. D., Brodbelt, J. S., Electrospray ionization of nucleic acid aptamer/small molecule complexes for screening aptamer selectivity. J. Mass Spectrom 2005, 40, 1327-1337.
117. Zhao, Y, Widen, S. G., Jamaluddin, M, Tian, B. et al., Quantification of activated NF-kB/RelA complexes using ss DNA aptamer affinity-stable isotope dilution selected reaction monitoring-mass spectrometry. Mol. Cell Proteomics 2011, 10, M111.008771.
118. Hecht, A. H., Sommer, G. J., Durland, R. H., Yang, X. et al., Aptamers as affinity reagents in an integrated electrophoretic lab-on-a-chip platform. Anal. Chem. 2010, 82, 8813-8820.
119. Bock, C., Coleman, M., Collins, B., Davis, J. et al., Photoaptamer arrays applied to multiplexed proteomic analysis. Proteomics 2004, 4, 609-618.
120. Kirby, R., Cho, E. J., Gehrke, B., Bayer, T. et al., Aptamer-based sensor arrays for the detection and quantification of proteins. Anal. Chem. 2004, 76, 4066-4075.
121. Brody, E. N., Willis, M. C., Smith, J. D., Jayasena, S. et al., The use of aptamers in large arrays for molecular diagnostics. Mol. Diagn. 1999, 4, 381-388.
122. Collett, J. R., Cho, E. J., Ellington, A. D., Production and processing of aptamer microarrays. Methods 2005, 37, 4-15.
123. McCauley, T. G., Hamaguchi, N., Stanton, M., Aptamer based biosensor arrays for detection and quantification of biological macromolecules. Anal. Biochem. 2003, 319, 244-250.